当恒瑞医药“放弃”自主出海

氨基观察
22 Oct 2024

风险这个东西,对于药企来说,应当最熟悉不过的。根据BIO等组织发布的关于药物临床开发成功率的报告,在统计完9704个药物的1.27万个临床开发项目后,BIO发现,2011年至2020年十年间,药物开发项目从1期临床到获得FDA批准上市的成功率平均为7.9%,所需要的时间平均为10.5年。对于国内药企来说,要面对的是比一生九死还要残酷的现实,因为还要面对出海的层层试炼。但海外市场是更宽阔的大海,通过...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10